Share this article on:

Breast Implant Illness: Symptoms, Patient Concerns, and the Power of Social Media

Tang, Sherry Y. Q. B.S.; Israel, Jacqueline S. M.D.; Afifi, Ahmed M. M.D.

Plastic and Reconstructive Surgery: November 2017 - Volume 140 - Issue 5 - p 765e–766e
doi: 10.1097/PRS.0000000000003785
Viewpoints

Division of Plastic Surgery, University of Wisconsin–Madison, Madison, Wis.

Division of Plastic Surgery, University of Wisconsin–Madison, Madison, Wis., Division of Plastic Surgery, Cairo University, Cairo, Egypt

Correspondence to Dr. Afifi, G5/361 Clinical Sciences Center, 600 Highland Avenue, Madison, Wis. 53792, afifi@surgery.wisc.edu

Back to Top | Article Outline

Sir:

Despite having been temporarily removed from the U.S. market in the late 1990s, breast implants are approved for use in augmentation and reconstruction. Although it is accepted that there is an association between implants and anaplastic large cell lymphoma, breast implants have not been shown to cause autoimmune disorders or other systemic illnesses.1,2 However, there is a cohort of women who pursue explantation because of what is referred to as “breast implant illness,”3 a term used to describe a constellation of symptoms and signs thought to be caused by implants.3 There is no known pathophysiologic explanation or diagnostic testing for breast implant illness. In addition, many of these patients have very specific requests for the explantation surgery, such as performing total capsulectomy, culture of the saline inside the implants, and intraoperative photographs.

To evaluate perceptions of breast implant illness, we reviewed online activity on two breast implant illness support groups (4200 and 18,800 members, respectively) on the popular social media site Facebook. We began by focusing on content relating to breast implant illness and augmentation. Of the 345 posts and comments reviewed, 165 (48 percent) describe a symptom of breast implant illness, such as fatigue, chronic pain, rash, body odor, irregular heart rate, anxiety, neurologic abnormalities, hair loss, and endocrine dysfunction. Forty-five percent reference surgical management by asking questions, recommending surgery, or describing their experience with explantation. No post or comment expresses regret after explantation. Amidst many posts describing frustration and distrust, several members relay positive experiences and express gratitude for support from fellow “Breasties” and surgeons who listened to their concerns (Table 1).

Table 1

Table 1

To assess breast implant illness specifically in the setting of reconstruction, we used the search terms “mastectomy” and “reconstruction” and reviewed 73 posts. Eighty-one percent of posts mention dissatisfaction, to which there are several attributing factors: 66 percent reference unexpected illness after implant placement and 58 percent report a general feeling of unwell. Forty-four percent of posts mention pursuing implant removal, 50 percent of which describe improvement after explantation.

For both augmentation and reconstruction, Facebook group members often express frustration with plastic surgeons when there is a perceived dismissal of symptoms (Table 2). Some symptoms may be attributable to indolent infection after implant placement, and surgeons should maintain a high index of suspicion for infections caused by atypical organisms.4 Individuals’ comorbidities should be evaluated to rule out unrelated causes. The thousands of individuals who share experience, seek support, and express frustration on social media, and the contrast in attitudes toward plastic surgeons expressed in posts found in Tables 1 and 2, suggest a gap in communication between many patients and their surgeons. We recommend validation of individual concerns and educating patients that we currently do not know of a mechanism by which implants can cause any of these systemic symptoms.2–5 However, surgeons should consider respecting the patient’s wishes, removing the implants, and informing the patient that roughly half of women with symptoms of breast implant illness may improve after explantation.

Table 2

Table 2

Back to Top | Article Outline

DISCLOSURE

The authors have no financial or commercial conflicts of interest to disclose.

Sherry Y. Q. Tang, B.S.

Jacqueline S. Israel, M.D.

Division of Plastic Surgery

University of Wisconsin–Madison

Madison, Wis.

Ahmed M. Afifi, M.D.

Division of Plastic Surgery

University of Wisconsin–Madison

Madison, Wis.

Division of Plastic Surgery

Cairo University

Cairo, Egypt

Back to Top | Article Outline

REFERENCES

1. U.S. Food and Drug Administration. Regulatory history of breast implants in the U.S. Available at: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm064461.htm. Accessed April 16, 2017.
2. Rohrich RJ, Kenkel JM, Adams WP, Beran S, Conner WC. A prospective analysis of patients undergoing silicone breast implant explantation. Plast Reconstr Surg. 2000;105:2529–2537; discussion 25382543.
3. Healing Breast Implant Illness. Breast implant safety. Available at: http://healingbreastimplantillness.com/breast-implant-safety/. Accessed April 18, 2017.
4. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis. 2005;5:94–106.
5. Fryzek JP, Signorello LB, Hakelius L, et al. Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg. 2001;107:206–213.
Back to Top | Article Outline

GUIDELINES

Viewpoints, pertaining to issues of general interest, are welcome, even if they are not related to items previously published. Viewpoints may present unique techniques, brief technology updates, technical notes, and so on. Viewpoints will be published on a space-available basis because they are typically less timesensitive than Letters and other types of articles. Please note the following criteria:

  • Text—maximum of 500 words (not including references)
  • References—maximum of five
  • Authors—no more than five
  • Figures/Tables—no more than two figures and/or one table

Authors will be listed in the order in which they appear in the submission. Viewpoints should be submitted electronically via PRS’ enkwell, at www.editorialmanager.com/prs/. We strongly encourage authors to submit figures in color.

We reserve the right to edit Viewpoints to meet requirements of space and format. Any financial interests relevant to the content must be disclosed. Submission of a Viewpoint constitutes permission for the American Society of Plastic Surgeons and its licensees and assignees to publish it in the Journal and in any other form or medium.

The views, opinions, and conclusions expressed in the Viewpoints represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the sponsors of the Journal. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence.

©2017American Society of Plastic Surgeons